Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer. Overview The Process Development Associate II, Late-Stage will provide technical and analytical support for Iovance’s commercial Amtagvi (lifileucel) asset and other pipeline products in development. In particular, the candidate will support both clinical and commercial development projects and will have prior cell culture, process development and cGLP/cGMP knowledge and experience. Priority will be given to candidates familiar with cell therapy development and relevant experience with equipment utilized in the field. In addition, candidates with demonstrated strong skills in data analysis and automation are preferred. This role is an on-site lab-based role in Philadelphia.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
251-500 employees